deltatrials
Terminated PHASE1/PHASE2 INTERVENTIONAL NCT00165594

A Study of E7070 in Patients With Gastric Cancer

Non-Randomized, Open, Uncontrolled, Dose Comparison Study of E7070 in Patients With Gastric Cancer

Sponsor: Eisai Co., Ltd.

Conditions Gastric Cancer
Interventions E7070
Updated 5 times since 2017 Last updated: Jan 22, 2014 Started: Feb 28, 2005 Primary completion: Jul 31, 2006 Completion: Aug 31, 2006
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Study was completed.

Other terminated trials from Eisai Co., Ltd.

More terminations from Eisai Co., Ltd.

Other Gastric Cancer trials with similar outcome

Browse all Gastric Cancer trials

This PHASE1/PHASE2 trial investigates Gastric Cancer and is currently terminated or withdrawn. Eisai Co., Ltd. leads this study, which shows 5 recorded versions since 2005 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 21 months · monthly snapshotTerminated

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE1/PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE1_PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE1_PHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Terminated PHASE1_PHASE2

    First recorded

Feb 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Eisai Co., Ltd.
Data source: Eisai Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations